D, G., KA, G., SK, G., P, G., S, Y., R, P., . . . V, G. (2026). Immunomodulation by juglone alleviates acute graft-versus-host disease without compromising the graft-versus-leukaemia activity in mice. British journal of pharmacology, 183(1), 131. https://doi.org/10.1111/bph.16350
Chicago Style (17th ed.) CitationD, Gohil, et al. "Immunomodulation by Juglone Alleviates Acute Graft-versus-host Disease Without Compromising the Graft-versus-leukaemia Activity in Mice." British Journal of Pharmacology 183, no. 1 (2026): 131. https://doi.org/10.1111/bph.16350.
MLA (9th ed.) CitationD, Gohil, et al. "Immunomodulation by Juglone Alleviates Acute Graft-versus-host Disease Without Compromising the Graft-versus-leukaemia Activity in Mice." British Journal of Pharmacology, vol. 183, no. 1, 2026, p. 131, https://doi.org/10.1111/bph.16350.